Cubist Systematic Strategies, LLC Emergent Bio Solutions Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.1 Billion
  • Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 198,373 shares of EBS stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
198,373
Previous 330,480 39.97%
Holding current value
$1.53 Million
Previous $2.76 Million 31.28%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$7.72 - $11.97 $1.02 Million - $1.58 Million
-132,107 Reduced 39.97%
198,373 $1.9 Million
Q3 2024

Nov 14, 2024
BUY
$5.72 - $14.77 $1.78 Million - $4.59 Million
310,760 Added 1575.86%
330,480 $2.76 Million
Q2 2024

Aug 14, 2024
SELL
$1.86 - $6.98 $40,302 - $151,242
-21,668 Reduced 52.35%
19,720 $134,000
Q1 2024

May 15, 2024
SELL
$1.5 - $3.41 $692,776 - $1.57 Million
-461,851 Reduced 91.78%
41,388 $104,000
Q4 2023

Feb 14, 2024
BUY
$1.82 - $3.16 $297,651 - $516,802
163,545 Added 48.14%
503,239 $1.21 Million
Q3 2023

Nov 14, 2023
BUY
$3.17 - $7.91 $576,556 - $1.44 Million
181,879 Added 115.25%
339,694 $1.15 Million
Q2 2023

Aug 14, 2023
SELL
$7.35 - $13.21 $43,350 - $77,912
-5,898 Reduced 3.6%
157,815 $1.16 Million
Q1 2023

May 15, 2023
BUY
$7.79 - $16.29 $333,006 - $696,364
42,748 Added 35.34%
163,713 $1.7 Million
Q4 2022

Feb 14, 2023
BUY
$11.0 - $21.45 $193,039 - $376,426
17,549 Added 16.97%
120,965 $1.43 Million
Q3 2022

Nov 14, 2022
BUY
$20.09 - $35.8 $1.65 Million - $2.94 Million
82,227 Added 388.06%
103,416 $2.17 Million
Q2 2022

Aug 15, 2022
SELL
$27.42 - $43.63 $1.74 Million - $2.77 Million
-63,424 Reduced 74.96%
21,189 $658,000
Q1 2022

May 16, 2022
SELL
$36.48 - $52.22 $595,463 - $852,387
-16,323 Reduced 16.17%
84,613 $3.47 Million
Q4 2021

Feb 14, 2022
BUY
$33.11 - $55.01 $2.85 Million - $4.73 Million
86,046 Added 577.88%
100,936 $4.39 Million
Q3 2021

Nov 15, 2021
SELL
$50.07 - $66.05 $1.57 Million - $2.07 Million
-31,406 Reduced 67.84%
14,890 $746,000
Q2 2021

Aug 16, 2021
BUY
$56.61 - $80.46 $1.51 Million - $2.15 Million
26,740 Added 136.74%
46,296 $2.92 Million
Q1 2021

May 17, 2021
BUY
$86.23 - $125.19 $527,123 - $765,286
6,113 Added 45.47%
19,556 $1.82 Million
Q4 2020

Feb 16, 2021
SELL
$79.17 - $111.47 $3.34 Million - $4.7 Million
-42,125 Reduced 75.81%
13,443 $1.2 Million
Q3 2020

Nov 16, 2020
BUY
$81.91 - $134.94 $4.27 Million - $7.04 Million
52,150 Added 1525.75%
55,568 $5.74 Million
Q2 2020

Aug 14, 2020
SELL
$54.33 - $89.52 $924,642 - $1.52 Million
-17,019 Reduced 83.28%
3,418 $270,000
Q1 2020

May 15, 2020
SELL
$49.34 - $68.76 $299,740 - $417,717
-6,075 Reduced 22.91%
20,437 $1.18 Million
Q4 2019

Feb 14, 2020
SELL
$51.21 - $59.06 $140,212 - $161,706
-2,738 Reduced 9.36%
26,512 $1.43 Million
Q3 2019

Nov 14, 2019
BUY
$40.6 - $57.2 $751,790 - $1.06 Million
18,517 Added 172.52%
29,250 $1.53 Million
Q2 2019

Aug 14, 2019
BUY
$39.92 - $53.86 $428,461 - $578,079
10,733 New
10,733 $519,000
Q1 2019

May 15, 2019
SELL
$48.23 - $66.16 $320,922 - $440,228
-6,654 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$55.63 - $73.24 $370,162 - $487,338
6,654 New
6,654 $394,000
Q3 2018

Nov 14, 2018
SELL
$52.05 - $66.51 $240,783 - $307,675
-4,626 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$48.33 - $55.64 $11,937 - $13,743
-247 Reduced 5.07%
4,626 $234,000
Q1 2018

May 15, 2018
SELL
$44.44 - $54.39 $369,829 - $452,633
-8,322 Reduced 63.07%
4,873 $257,000
Q4 2017

Feb 14, 2018
BUY
$37.77 - $47.75 $279,762 - $353,684
7,407 Added 127.97%
13,195 $613,000
Q3 2017

Nov 14, 2017
BUY
$34.14 - $40.45 $197,602 - $234,124
5,788
5,788 $234,000

Others Institutions Holding EBS

# of Institutions
172
Shares Held
36.8M
Call Options Held
336K
Put Options Held
203K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email